nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.156	0.248	CbGbCtD
Tadalafil—CYP3A4—Triamcinolone—ankylosing spondylitis	0.119	0.188	CbGbCtD
Tadalafil—CYP3A4—Betamethasone—ankylosing spondylitis	0.102	0.161	CbGbCtD
Tadalafil—CYP3A4—Prednisolone—ankylosing spondylitis	0.1	0.159	CbGbCtD
Tadalafil—CYP3A4—Prednisone—ankylosing spondylitis	0.0948	0.15	CbGbCtD
Tadalafil—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0592	0.0938	CbGbCtD
Tadalafil—Haemorrhage—Prednisone—ankylosing spondylitis	0.00112	0.00302	CcSEcCtD
Tadalafil—Vertigo—Triamcinolone—ankylosing spondylitis	0.0011	0.00299	CcSEcCtD
Tadalafil—Syncope—Triamcinolone—ankylosing spondylitis	0.0011	0.00299	CcSEcCtD
Tadalafil—Vertigo—Methylprednisolone—ankylosing spondylitis	0.0011	0.00299	CcSEcCtD
Tadalafil—Syncope—Methylprednisolone—ankylosing spondylitis	0.0011	0.00298	CcSEcCtD
Tadalafil—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.0011	0.00297	CcSEcCtD
Tadalafil—Oedema—Prednisolone—ankylosing spondylitis	0.00109	0.00296	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00108	0.00293	CcSEcCtD
Tadalafil—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00108	0.00293	CcSEcCtD
Tadalafil—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00108	0.00292	CcSEcCtD
Tadalafil—Shock—Prednisolone—ankylosing spondylitis	0.00107	0.00291	CcSEcCtD
Tadalafil—Cough—Triamcinolone—ankylosing spondylitis	0.00107	0.00291	CcSEcCtD
Tadalafil—Convulsion—Triamcinolone—ankylosing spondylitis	0.00106	0.00289	CcSEcCtD
Tadalafil—Tachycardia—Prednisolone—ankylosing spondylitis	0.00106	0.00289	CcSEcCtD
Tadalafil—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00106	0.00288	CcSEcCtD
Tadalafil—Hypertension—Triamcinolone—ankylosing spondylitis	0.00106	0.00288	CcSEcCtD
Tadalafil—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00106	0.00287	CcSEcCtD
Tadalafil—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00105	0.00286	CcSEcCtD
Tadalafil—Myalgia—Triamcinolone—ankylosing spondylitis	0.00105	0.00284	CcSEcCtD
Tadalafil—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00104	0.00283	CcSEcCtD
Tadalafil—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00104	0.00283	CcSEcCtD
Tadalafil—Eye disorder—Prednisone—ankylosing spondylitis	0.00104	0.00283	CcSEcCtD
Tadalafil—Infestation—Methotrexate—ankylosing spondylitis	0.00104	0.00282	CcSEcCtD
Tadalafil—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00104	0.00282	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00104	0.00281	CcSEcCtD
Tadalafil—Flushing—Prednisone—ankylosing spondylitis	0.00104	0.00281	CcSEcCtD
Tadalafil—Discomfort—Triamcinolone—ankylosing spondylitis	0.00103	0.0028	CcSEcCtD
Tadalafil—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00103	0.0028	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00103	0.00279	CcSEcCtD
Tadalafil—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00102	0.00277	CcSEcCtD
Tadalafil—Renal failure—Methotrexate—ankylosing spondylitis	0.00102	0.00277	CcSEcCtD
Tadalafil—Angioedema—Dexamethasone—ankylosing spondylitis	0.00102	0.00276	CcSEcCtD
Tadalafil—Angioedema—Betamethasone—ankylosing spondylitis	0.00102	0.00276	CcSEcCtD
Tadalafil—Angiopathy—Prednisone—ankylosing spondylitis	0.00101	0.00274	CcSEcCtD
Tadalafil—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00101	0.00274	CcSEcCtD
Tadalafil—Immune system disorder—Prednisone—ankylosing spondylitis	0.00101	0.00273	CcSEcCtD
Tadalafil—Oedema—Triamcinolone—ankylosing spondylitis	0.001	0.00272	CcSEcCtD
Tadalafil—Vertigo—Betamethasone—ankylosing spondylitis	0.001	0.00272	CcSEcCtD
Tadalafil—Vertigo—Dexamethasone—ankylosing spondylitis	0.001	0.00272	CcSEcCtD
Tadalafil—Syncope—Betamethasone—ankylosing spondylitis	0.001	0.00271	CcSEcCtD
Tadalafil—Syncope—Dexamethasone—ankylosing spondylitis	0.001	0.00271	CcSEcCtD
Tadalafil—Infection—Triamcinolone—ankylosing spondylitis	0.000997	0.0027	CcSEcCtD
Tadalafil—Sweating—Methotrexate—ankylosing spondylitis	0.000996	0.0027	CcSEcCtD
Tadalafil—Infection—Methylprednisolone—ankylosing spondylitis	0.000994	0.0027	CcSEcCtD
Tadalafil—Haematuria—Methotrexate—ankylosing spondylitis	0.00099	0.00268	CcSEcCtD
Tadalafil—Shock—Triamcinolone—ankylosing spondylitis	0.000987	0.00268	CcSEcCtD
Tadalafil—Insomnia—Prednisolone—ankylosing spondylitis	0.000987	0.00267	CcSEcCtD
Tadalafil—Shock—Methylprednisolone—ankylosing spondylitis	0.000985	0.00267	CcSEcCtD
Tadalafil—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000982	0.00266	CcSEcCtD
Tadalafil—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00098	0.00266	CcSEcCtD
Tadalafil—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00098	0.00266	CcSEcCtD
Tadalafil—Epistaxis—Methotrexate—ankylosing spondylitis	0.00098	0.00266	CcSEcCtD
Tadalafil—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000979	0.00265	CcSEcCtD
Tadalafil—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000979	0.00265	CcSEcCtD
Tadalafil—Mental disorder—Prednisone—ankylosing spondylitis	0.000977	0.00265	CcSEcCtD
Tadalafil—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000977	0.00265	CcSEcCtD
Tadalafil—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000972	0.00264	CcSEcCtD
Tadalafil—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00097	0.00263	CcSEcCtD
Tadalafil—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000968	0.00262	CcSEcCtD
Tadalafil—Convulsion—Dexamethasone—ankylosing spondylitis	0.000966	0.00262	CcSEcCtD
Tadalafil—Convulsion—Betamethasone—ankylosing spondylitis	0.000966	0.00262	CcSEcCtD
Tadalafil—Hypertension—Betamethasone—ankylosing spondylitis	0.000963	0.00261	CcSEcCtD
Tadalafil—Hypertension—Dexamethasone—ankylosing spondylitis	0.000963	0.00261	CcSEcCtD
Tadalafil—Myalgia—Betamethasone—ankylosing spondylitis	0.000949	0.00257	CcSEcCtD
Tadalafil—Myalgia—Dexamethasone—ankylosing spondylitis	0.000949	0.00257	CcSEcCtD
Tadalafil—Discomfort—Betamethasone—ankylosing spondylitis	0.000938	0.00254	CcSEcCtD
Tadalafil—Discomfort—Dexamethasone—ankylosing spondylitis	0.000938	0.00254	CcSEcCtD
Tadalafil—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000937	0.00254	CcSEcCtD
Tadalafil—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000935	0.00254	CcSEcCtD
Tadalafil—Pain—Prednisolone—ankylosing spondylitis	0.000933	0.00253	CcSEcCtD
Tadalafil—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000932	0.00253	CcSEcCtD
Tadalafil—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000925	0.00251	CcSEcCtD
Tadalafil—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000921	0.0025	CcSEcCtD
Tadalafil—Vision blurred—Prednisone—ankylosing spondylitis	0.000915	0.00248	CcSEcCtD
Tadalafil—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000914	0.00248	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000914	0.00248	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000912	0.00247	CcSEcCtD
Tadalafil—Oedema—Dexamethasone—ankylosing spondylitis	0.00091	0.00247	CcSEcCtD
Tadalafil—Oedema—Betamethasone—ankylosing spondylitis	0.00091	0.00247	CcSEcCtD
Tadalafil—Insomnia—Triamcinolone—ankylosing spondylitis	0.000907	0.00246	CcSEcCtD
Tadalafil—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000905	0.00245	CcSEcCtD
Tadalafil—Infection—Betamethasone—ankylosing spondylitis	0.000904	0.00245	CcSEcCtD
Tadalafil—Infection—Dexamethasone—ankylosing spondylitis	0.000904	0.00245	CcSEcCtD
Tadalafil—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000901	0.00244	CcSEcCtD
Tadalafil—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000899	0.00244	CcSEcCtD
Tadalafil—Shock—Dexamethasone—ankylosing spondylitis	0.000895	0.00243	CcSEcCtD
Tadalafil—Shock—Betamethasone—ankylosing spondylitis	0.000895	0.00243	CcSEcCtD
Tadalafil—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000894	0.00242	CcSEcCtD
Tadalafil—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000893	0.00242	CcSEcCtD
Tadalafil—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000893	0.00242	CcSEcCtD
Tadalafil—Tachycardia—Betamethasone—ankylosing spondylitis	0.000888	0.00241	CcSEcCtD
Tadalafil—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000888	0.00241	CcSEcCtD
Tadalafil—Angioedema—Prednisone—ankylosing spondylitis	0.000887	0.00241	CcSEcCtD
Tadalafil—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000883	0.00239	CcSEcCtD
Tadalafil—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000882	0.00239	CcSEcCtD
Tadalafil—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000881	0.00239	CcSEcCtD
Tadalafil—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00088	0.00239	CcSEcCtD
Tadalafil—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00088	0.00239	CcSEcCtD
Tadalafil—Vertigo—Prednisone—ankylosing spondylitis	0.000873	0.00237	CcSEcCtD
Tadalafil—Eye disorder—Methotrexate—ankylosing spondylitis	0.000871	0.00236	CcSEcCtD
Tadalafil—Syncope—Prednisone—ankylosing spondylitis	0.000871	0.00236	CcSEcCtD
Tadalafil—Tinnitus—Methotrexate—ankylosing spondylitis	0.000869	0.00236	CcSEcCtD
Tadalafil—Urticaria—Prednisolone—ankylosing spondylitis	0.000867	0.00235	CcSEcCtD
Tadalafil—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000865	0.00235	CcSEcCtD
Tadalafil—Fatigue—Triamcinolone—ankylosing spondylitis	0.000865	0.00234	CcSEcCtD
Tadalafil—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000863	0.00234	CcSEcCtD
Tadalafil—Pain—Triamcinolone—ankylosing spondylitis	0.000858	0.00233	CcSEcCtD
Tadalafil—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000854	0.00231	CcSEcCtD
Tadalafil—Hypotension—Betamethasone—ankylosing spondylitis	0.000851	0.00231	CcSEcCtD
Tadalafil—Hypotension—Dexamethasone—ankylosing spondylitis	0.000851	0.00231	CcSEcCtD
Tadalafil—Angiopathy—Methotrexate—ankylosing spondylitis	0.000846	0.00229	CcSEcCtD
Tadalafil—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000842	0.00228	CcSEcCtD
Tadalafil—Convulsion—Prednisone—ankylosing spondylitis	0.000842	0.00228	CcSEcCtD
Tadalafil—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00084	0.00228	CcSEcCtD
Tadalafil—Hypertension—Prednisone—ankylosing spondylitis	0.000839	0.00227	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000829	0.00225	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000829	0.00225	CcSEcCtD
Tadalafil—Myalgia—Prednisone—ankylosing spondylitis	0.000827	0.00224	CcSEcCtD
Tadalafil—Arthralgia—Prednisone—ankylosing spondylitis	0.000827	0.00224	CcSEcCtD
Tadalafil—Insomnia—Dexamethasone—ankylosing spondylitis	0.000823	0.00223	CcSEcCtD
Tadalafil—Insomnia—Betamethasone—ankylosing spondylitis	0.000823	0.00223	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000821	0.00223	CcSEcCtD
Tadalafil—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000818	0.00222	CcSEcCtD
Tadalafil—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000817	0.00222	CcSEcCtD
Tadalafil—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000817	0.00222	CcSEcCtD
Tadalafil—Discomfort—Prednisone—ankylosing spondylitis	0.000817	0.00221	CcSEcCtD
Tadalafil—Mental disorder—Methotrexate—ankylosing spondylitis	0.000817	0.00221	CcSEcCtD
Tadalafil—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000804	0.00218	CcSEcCtD
Tadalafil—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000801	0.00217	CcSEcCtD
Tadalafil—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000801	0.00217	CcSEcCtD
Tadalafil—Urticaria—Triamcinolone—ankylosing spondylitis	0.000797	0.00216	CcSEcCtD
Tadalafil—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000795	0.00216	CcSEcCtD
Tadalafil—Oedema—Prednisone—ankylosing spondylitis	0.000793	0.00215	CcSEcCtD
Tadalafil—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000791	0.00214	CcSEcCtD
Tadalafil—Infection—Prednisone—ankylosing spondylitis	0.000787	0.00213	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000786	0.00213	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000786	0.00213	CcSEcCtD
Tadalafil—Back pain—Methotrexate—ankylosing spondylitis	0.000785	0.00213	CcSEcCtD
Tadalafil—Fatigue—Betamethasone—ankylosing spondylitis	0.000785	0.00213	CcSEcCtD
Tadalafil—Fatigue—Dexamethasone—ankylosing spondylitis	0.000785	0.00213	CcSEcCtD
Tadalafil—Shock—Prednisone—ankylosing spondylitis	0.00078	0.00211	CcSEcCtD
Tadalafil—Pain—Dexamethasone—ankylosing spondylitis	0.000778	0.00211	CcSEcCtD
Tadalafil—Pain—Betamethasone—ankylosing spondylitis	0.000778	0.00211	CcSEcCtD
Tadalafil—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000777	0.00211	CcSEcCtD
Tadalafil—Tachycardia—Prednisone—ankylosing spondylitis	0.000774	0.0021	CcSEcCtD
Tadalafil—Skin disorder—Prednisone—ankylosing spondylitis	0.00077	0.00209	CcSEcCtD
Tadalafil—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000766	0.00208	CcSEcCtD
Tadalafil—Vision blurred—Methotrexate—ankylosing spondylitis	0.000765	0.00207	CcSEcCtD
Tadalafil—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000744	0.00202	CcSEcCtD
Tadalafil—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000744	0.00202	CcSEcCtD
Tadalafil—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000739	0.002	CcSEcCtD
Tadalafil—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000737	0.002	CcSEcCtD
Tadalafil—Vertigo—Methotrexate—ankylosing spondylitis	0.000729	0.00198	CcSEcCtD
Tadalafil—Urticaria—Dexamethasone—ankylosing spondylitis	0.000723	0.00196	CcSEcCtD
Tadalafil—Urticaria—Betamethasone—ankylosing spondylitis	0.000723	0.00196	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000722	0.00196	CcSEcCtD
Tadalafil—Dizziness—Prednisolone—ankylosing spondylitis	0.000721	0.00196	CcSEcCtD
Tadalafil—Asthenia—Triamcinolone—ankylosing spondylitis	0.00072	0.00195	CcSEcCtD
Tadalafil—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00072	0.00195	CcSEcCtD
Tadalafil—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00072	0.00195	CcSEcCtD
Tadalafil—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000718	0.00195	CcSEcCtD
Tadalafil—Insomnia—Prednisone—ankylosing spondylitis	0.000717	0.00194	CcSEcCtD
Tadalafil—Paraesthesia—Prednisone—ankylosing spondylitis	0.000712	0.00193	CcSEcCtD
Tadalafil—Pruritus—Triamcinolone—ankylosing spondylitis	0.00071	0.00192	CcSEcCtD
Tadalafil—Cough—Methotrexate—ankylosing spondylitis	0.000708	0.00192	CcSEcCtD
Tadalafil—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000708	0.00192	CcSEcCtD
Tadalafil—Convulsion—Methotrexate—ankylosing spondylitis	0.000703	0.00191	CcSEcCtD
Tadalafil—Dyspepsia—Prednisone—ankylosing spondylitis	0.000698	0.00189	CcSEcCtD
Tadalafil—Arthralgia—Methotrexate—ankylosing spondylitis	0.000691	0.00187	CcSEcCtD
Tadalafil—Chest pain—Methotrexate—ankylosing spondylitis	0.000691	0.00187	CcSEcCtD
Tadalafil—Myalgia—Methotrexate—ankylosing spondylitis	0.000691	0.00187	CcSEcCtD
Tadalafil—Rash—Prednisolone—ankylosing spondylitis	0.000688	0.00186	CcSEcCtD
Tadalafil—Dermatitis—Prednisolone—ankylosing spondylitis	0.000687	0.00186	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000686	0.00186	CcSEcCtD
Tadalafil—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000685	0.00186	CcSEcCtD
Tadalafil—Fatigue—Prednisone—ankylosing spondylitis	0.000683	0.00185	CcSEcCtD
Tadalafil—Headache—Prednisolone—ankylosing spondylitis	0.000683	0.00185	CcSEcCtD
Tadalafil—Discomfort—Methotrexate—ankylosing spondylitis	0.000683	0.00185	CcSEcCtD
Tadalafil—Constipation—Prednisone—ankylosing spondylitis	0.000678	0.00184	CcSEcCtD
Tadalafil—Dizziness—Triamcinolone—ankylosing spondylitis	0.000663	0.0018	CcSEcCtD
Tadalafil—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000662	0.00179	CcSEcCtD
Tadalafil—Infection—Methotrexate—ankylosing spondylitis	0.000658	0.00178	CcSEcCtD
Tadalafil—Asthenia—Betamethasone—ankylosing spondylitis	0.000653	0.00177	CcSEcCtD
Tadalafil—Asthenia—Dexamethasone—ankylosing spondylitis	0.000653	0.00177	CcSEcCtD
Tadalafil—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00065	0.00176	CcSEcCtD
Tadalafil—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000648	0.00176	CcSEcCtD
Tadalafil—Nausea—Prednisolone—ankylosing spondylitis	0.000648	0.00176	CcSEcCtD
Tadalafil—Pruritus—Betamethasone—ankylosing spondylitis	0.000644	0.00175	CcSEcCtD
Tadalafil—Pruritus—Dexamethasone—ankylosing spondylitis	0.000644	0.00175	CcSEcCtD
Tadalafil—Skin disorder—Methotrexate—ankylosing spondylitis	0.000643	0.00174	CcSEcCtD
Tadalafil—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00064	0.00174	CcSEcCtD
Tadalafil—Vomiting—Triamcinolone—ankylosing spondylitis	0.000638	0.00173	CcSEcCtD
Tadalafil—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000636	0.00172	CcSEcCtD
Tadalafil—Rash—Triamcinolone—ankylosing spondylitis	0.000632	0.00171	CcSEcCtD
Tadalafil—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000632	0.00171	CcSEcCtD
Tadalafil—Rash—Methylprednisolone—ankylosing spondylitis	0.000631	0.00171	CcSEcCtD
Tadalafil—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00063	0.00171	CcSEcCtD
Tadalafil—Urticaria—Prednisone—ankylosing spondylitis	0.00063	0.00171	CcSEcCtD
Tadalafil—Headache—Triamcinolone—ankylosing spondylitis	0.000628	0.0017	CcSEcCtD
Tadalafil—Headache—Methylprednisolone—ankylosing spondylitis	0.000627	0.0017	CcSEcCtD
Tadalafil—Abdominal pain—Prednisone—ankylosing spondylitis	0.000627	0.0017	CcSEcCtD
Tadalafil—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000623	0.00169	CcSEcCtD
Tadalafil—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000623	0.00169	CcSEcCtD
Tadalafil—Hypotension—Methotrexate—ankylosing spondylitis	0.000619	0.00168	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000604	0.00164	CcSEcCtD
Tadalafil—Dizziness—Dexamethasone—ankylosing spondylitis	0.000602	0.00163	CcSEcCtD
Tadalafil—Dizziness—Betamethasone—ankylosing spondylitis	0.000602	0.00163	CcSEcCtD
Tadalafil—Insomnia—Methotrexate—ankylosing spondylitis	0.000599	0.00162	CcSEcCtD
Tadalafil—Nausea—Triamcinolone—ankylosing spondylitis	0.000596	0.00162	CcSEcCtD
Tadalafil—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000595	0.00161	CcSEcCtD
Tadalafil—Nausea—Methylprednisolone—ankylosing spondylitis	0.000595	0.00161	CcSEcCtD
Tadalafil—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000591	0.0016	CcSEcCtD
Tadalafil—Somnolence—Methotrexate—ankylosing spondylitis	0.000589	0.0016	CcSEcCtD
Tadalafil—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000584	0.00158	CcSEcCtD
Tadalafil—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000583	0.00158	CcSEcCtD
Tadalafil—Vomiting—Betamethasone—ankylosing spondylitis	0.000579	0.00157	CcSEcCtD
Tadalafil—Vomiting—Dexamethasone—ankylosing spondylitis	0.000579	0.00157	CcSEcCtD
Tadalafil—Rash—Betamethasone—ankylosing spondylitis	0.000574	0.00156	CcSEcCtD
Tadalafil—Rash—Dexamethasone—ankylosing spondylitis	0.000574	0.00156	CcSEcCtD
Tadalafil—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000573	0.00155	CcSEcCtD
Tadalafil—Dermatitis—Betamethasone—ankylosing spondylitis	0.000573	0.00155	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000572	0.00155	CcSEcCtD
Tadalafil—Fatigue—Methotrexate—ankylosing spondylitis	0.000571	0.00155	CcSEcCtD
Tadalafil—Headache—Dexamethasone—ankylosing spondylitis	0.00057	0.00155	CcSEcCtD
Tadalafil—Headache—Betamethasone—ankylosing spondylitis	0.00057	0.00155	CcSEcCtD
Tadalafil—Asthenia—Prednisone—ankylosing spondylitis	0.000569	0.00154	CcSEcCtD
Tadalafil—Pain—Methotrexate—ankylosing spondylitis	0.000566	0.00154	CcSEcCtD
Tadalafil—Pruritus—Prednisone—ankylosing spondylitis	0.000561	0.00152	CcSEcCtD
Tadalafil—Diarrhoea—Prednisone—ankylosing spondylitis	0.000542	0.00147	CcSEcCtD
Tadalafil—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000542	0.00147	CcSEcCtD
Tadalafil—Nausea—Betamethasone—ankylosing spondylitis	0.000541	0.00147	CcSEcCtD
Tadalafil—Nausea—Dexamethasone—ankylosing spondylitis	0.000541	0.00147	CcSEcCtD
Tadalafil—Urticaria—Methotrexate—ankylosing spondylitis	0.000526	0.00143	CcSEcCtD
Tadalafil—Dizziness—Prednisone—ankylosing spondylitis	0.000524	0.00142	CcSEcCtD
Tadalafil—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000524	0.00142	CcSEcCtD
Tadalafil—Vomiting—Prednisone—ankylosing spondylitis	0.000504	0.00137	CcSEcCtD
Tadalafil—Rash—Prednisone—ankylosing spondylitis	0.0005	0.00135	CcSEcCtD
Tadalafil—Dermatitis—Prednisone—ankylosing spondylitis	0.000499	0.00135	CcSEcCtD
Tadalafil—Headache—Prednisone—ankylosing spondylitis	0.000497	0.00135	CcSEcCtD
Tadalafil—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000488	0.00132	CcSEcCtD
Tadalafil—Asthenia—Methotrexate—ankylosing spondylitis	0.000475	0.00129	CcSEcCtD
Tadalafil—Nausea—Prednisone—ankylosing spondylitis	0.000471	0.00128	CcSEcCtD
Tadalafil—Pruritus—Methotrexate—ankylosing spondylitis	0.000469	0.00127	CcSEcCtD
Tadalafil—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000453	0.00123	CcSEcCtD
Tadalafil—Dizziness—Methotrexate—ankylosing spondylitis	0.000438	0.00119	CcSEcCtD
Tadalafil—Vomiting—Methotrexate—ankylosing spondylitis	0.000421	0.00114	CcSEcCtD
Tadalafil—Rash—Methotrexate—ankylosing spondylitis	0.000418	0.00113	CcSEcCtD
Tadalafil—Dermatitis—Methotrexate—ankylosing spondylitis	0.000417	0.00113	CcSEcCtD
Tadalafil—Headache—Methotrexate—ankylosing spondylitis	0.000415	0.00112	CcSEcCtD
Tadalafil—Nausea—Methotrexate—ankylosing spondylitis	0.000393	0.00107	CcSEcCtD
